Avalon GloboCare Corp. (ALBT)
| Market Cap | 2.67M -58.3% |
| Revenue (ttm) | n/a |
| Net Income | -20.26M |
| EPS | -4.02 |
| Shares Out | 8.32M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 71,985 |
| Open | 0.3413 |
| Previous Close | 0.3408 |
| Day's Range | 0.3207 - 0.3459 |
| 52-Week Range | 0.2100 - 4.7400 |
| Beta | -0.05 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 11, 2026 |
About ALBT
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the ... [Read more]
Financial Performance
Financial StatementsNews
Avalon teams with Caylent, AWS to develop Catch-Up AI video platform
Avalon (ALBT) GloboCare announced that its subsidiary, Avalon Quantum AI, is collaborating with Amazon (AMZN) Web Services, AWS, to support Phase 2 development of its Catch-Up agentic AI video platfor...
Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development
AWS collaboration accelerates Catch-Up Phase 2 development to a fully autonomous Agentic AI Video Platform AWS collaboration accelerates Catch-Up Phase 2 development to a fully autonomous Agentic AI V...
Avalon files to sell 19.44M shares of common stock for holders
17:20 EDT Avalon (ALBT) files to sell 19.44M shares of common stock for holders
Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules
$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of Warrants $3.25 Million Upfront With up to Approximately $6.5 Million of Potenti...
Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules
$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of Warrants $3.25 Million Upfront With up to Approximately $6.5 Million of Potenti...
Avalon GloboCare Stock (ALBT) Rockets on Acceptance Into AMD’s AI Developer Program
Avalon GloboCare stock was on the rise after the company was accepted into AMD’s AI Developer Program.
Avalon subsidiary accepted into AMD AI developer program
Avalon GloboCare (ALBT) announced that it has been accepted into the Advanced Micro Devices (AMD) AI Developer Program, providing the Company with access to AMD Developer Cloud credits, advanced tools...
Avalon GloboCare’s subsidiary files third U.S. provisional patent
Avalon (ALBT) GloboCare announced that its subsidiary, Avalon Quantum AI, has filed a new U.S. provisional patent application covering an artificial intelligence-driven system designed to generate mul...
Avalon eliminates majority of debentures through $2.6M conversion
Avalon (ALBT) GloboCare announced the conversion of the majority of its outstanding debentures, significantly strengthening the Company’s balance sheet. The debentures originated from a June 2024 inst...
Avalon subsidiary files U.S. patent application on new class of gen AI systems
Avalon (ALBT) GloboCare announced that its subsidiary, Avalon Quantum AI, has filed a U.S. provisional patent application covering a new class of generative AI systems designed to produce automated vi...
Avalon announces renewal of U.S. FDA registration for KetoAir
Avalon (ALBT) GloboCare announced the renewal of the U.S. Food and Drug Administration, FDA, establishment registration for the KetoAir device by Qi Diagnostics Limited, a nanosensor-based diagnostic ...
Avalon regains compliance with Nasdaq stockholders’ equity rule
Avalon (ALBT) GloboCare received notice from The Nasdaq Stock Market informing the Company that it has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement und...
Avalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video Platform
FREEHOLD, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer p...
Avalon GloboCare Board Director Highlights RPM Interactive's Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com
FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that Michael...
E.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCare
NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a leading investment bank providing strategic advisory and capital markets services, today is proud to have served as exclusive financial...
Avalon acquires RPM Interactive in all-stock transaction
Avalon (ALBT) GloboCare announced that it has acquired RPM Interactive in an all-stock transaction. As a result of the acquisition, the Company believes its stockholders’ equity now exceeds the $2.5M…
Myseum completes sales of minority stake in RPM Interactive for $6.5M
Myseum (MYSE) announced the completion of the sale of its approximately 34% ownership interest in RPM Interactive as part of a 100% acquisition of RPM by Avalon GloboCare (ALBT). Under…
Myseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare Acquisition
NEW BRUNSWICK, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”) today announced the completion of the sale of its approximately 34% ownership interest in...
Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction
Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisition Acquisition expected to resolve Nasdaq minimum stockholders' equity deficiency RPM Interactive has developed ...
Avalon announces Q3 advancements for KetoAir
Key Highlights: Launched Holistic Health Reset Program with First Responders in Nevada: In August 2025, Avalon (ALBT), together with Saga Health and SpecialtyHealth, Inc., launched the “Nevada POOL/PA...
Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion
FREEHOLD, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced a series of ...
Avalon to launch online sales of KetoAir Breathalyzer in UK
Avalon (ALBT) GloboCare announced that it will launch the sales of KetoAir breathalyzer device and related accessories in the United Kingdom, UK. The products will be available for purchase starting…
Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom
FREEHOLD, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it will...
Avalon enters distribution agreement with Saga Health for KetoAir
Avalon (ALBT) GloboCare announced that its subsidiary, Q&A Distribution, LLC, has entered into a wholesale distribution agreement with Saga Health Corporation for its use of the KetoAir breathalyzer d...
Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders
FREEHOLD, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that its sub...